Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ethan Dmitrovsky

Showing results (51-60 of 85) with videos related to

Pageof 9
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2007
A proof-of-principle clinical trial of bexarotene in patients with non-small cell lung cancerKonstantin H Dragnev, W Jeffrey Petty, Sumit J Shah, et al.
Molecular Cancer Therapeutics|August 24, 2016
Dinaciclib Induces Anaphase Catastrophe in Lung Cancer Cells via Inhibition of Cyclin-Dependent Kinases 1 and 2Alexey V Danilov, Shanhu Hu, Bernardo Orr, et al.
JNCI Cancer Spectrum|September 13, 2024
Glycemic control in diabetic patients improved overall lung cancer survival across diverse populationsWayne Y Wu, Brian Luke, Xiao-Cheng Wu, et al.
Cancer Research|October 12, 2010
Blockade of the ubiquitin protease UBP43 destabilizes transcription factor PML/RARα and inhibits the growth of acute promyelocytic leukemiaYongli Guo, Andrey V Dolinko, Fadzai Chinyengetere, et al.
Molecular Cancer Therapeutics|December 17, 2008
UBE1L causes lung cancer growth suppression by targeting cyclin D1Qing Feng, David Sekula, Yongli Guo, et al.
JCI Insight|April 15, 2025
CDK2 inhibition produces a persistent population of polyploid cancer cellsLiliya Tyutyunyk-Massey, Zibo Chen, Xiuxia Liu, et al.
The Journal of Experimental Medicine|August 24, 2011
A retinoic acid-dependent checkpoint in the development of CD4+ T cell-mediated immunityKarina Pino-Lagos, Yanxia Guo, Chrysothemis Brown, et al.
Cancer Research|November 3, 2004
Microarray analyses uncover UBE1L as a candidate target gene for lung cancer chemopreventionIan Pitha-Rowe, W Jeffrey Petty, Qing Feng, et al.
International Journal of Oncology|January 5, 2007
Repression of cyclin D1 as a target for germ cell tumorsSarah J Freemantle, Angelina V Vaseva, Katherine E Ewings, et al.
Cancer Research|August 21, 2012
A retinoic acid--rich tumor microenvironment provides clonal survival cues for tumor-specific CD8(+) T cellsYanxia Guo, Karina Pino-Lagos, Cory A Ahonen, et al.
Pageof 9

Showing results (51-60 of 85) with videos related to

Sort By:
Pageof 9
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2007
A proof-of-principle clinical trial of bexarotene in patients with non-small cell lung cancerKonstantin H Dragnev, W Jeffrey Petty, Sumit J Shah, et al.
Molecular Cancer Therapeutics|August 24, 2016
Dinaciclib Induces Anaphase Catastrophe in Lung Cancer Cells via Inhibition of Cyclin-Dependent Kinases 1 and 2Alexey V Danilov, Shanhu Hu, Bernardo Orr, et al.
JNCI Cancer Spectrum|September 13, 2024
Glycemic control in diabetic patients improved overall lung cancer survival across diverse populationsWayne Y Wu, Brian Luke, Xiao-Cheng Wu, et al.
Cancer Research|October 12, 2010
Blockade of the ubiquitin protease UBP43 destabilizes transcription factor PML/RARα and inhibits the growth of acute promyelocytic leukemiaYongli Guo, Andrey V Dolinko, Fadzai Chinyengetere, et al.
Molecular Cancer Therapeutics|December 17, 2008
UBE1L causes lung cancer growth suppression by targeting cyclin D1Qing Feng, David Sekula, Yongli Guo, et al.
JCI Insight|April 15, 2025
CDK2 inhibition produces a persistent population of polyploid cancer cellsLiliya Tyutyunyk-Massey, Zibo Chen, Xiuxia Liu, et al.
The Journal of Experimental Medicine|August 24, 2011
A retinoic acid-dependent checkpoint in the development of CD4+ T cell-mediated immunityKarina Pino-Lagos, Yanxia Guo, Chrysothemis Brown, et al.
Cancer Research|November 3, 2004
Microarray analyses uncover UBE1L as a candidate target gene for lung cancer chemopreventionIan Pitha-Rowe, W Jeffrey Petty, Qing Feng, et al.
International Journal of Oncology|January 5, 2007
Repression of cyclin D1 as a target for germ cell tumorsSarah J Freemantle, Angelina V Vaseva, Katherine E Ewings, et al.
Cancer Research|August 21, 2012
A retinoic acid--rich tumor microenvironment provides clonal survival cues for tumor-specific CD8(+) T cellsYanxia Guo, Karina Pino-Lagos, Cory A Ahonen, et al.
Pageof 9